-+ 0.00%
-+ 0.00%
-+ 0.00%

Everest Medicines appoints ex-Moderna executive Lakshmi Srinivasan as head of translational medicine

PUBT·10/09/2026 02:13:45
Listen to the news
Everest Medicines appoints ex-Moderna executive Lakshmi Srinivasan as head of translational medicine
  • Everest Medicines appointed Lakshmi Srinivasan as senior vice president, head of translational medicine.
  • Srinivasan previously led oncology translational medicine at Moderna from 2023 to 2025.
  • Brandon Coder joined as vice president, translational sciences and discovery.
  • Coder was most recently associate scientific director of cancer vaccine research at Moderna, where he helped lead mRNA-4157/V940 work.
  • Moves support planned EVM16 Phase 1b investigator-initiated trial in Q4 2026, U.S. IND filing in early 2027, EVM14 Phase 1 completion in Q1 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610082213PR_NEWS_USPR_____CN67628) on October 09, 2026, and is solely responsible for the information contained therein.